SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Surgical Care Affiliates Inc – ‘10-Q’ for 3/31/95

As of:  Thursday, 5/11/95   ·   For:  3/31/95   ·   Accession #:  950144-95-1269   ·   File #:  0-13364

Previous ‘10-Q’:  ‘10-Q’ on 11/10/94 for 9/30/94   ·   Next:  ‘10-Q’ on 8/2/95 for 6/30/95   ·   Latest:  ‘10-Q’ on 11/1/95 for 9/30/95

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/11/95  Surgical Care Affiliates Inc      10-Q        3/31/95    3:270K                                   Bowne of Atlanta Inc/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Surgical Care Form 10-Q                               11     44K 
 2: EX-10.1     Credit Agreement                                     114    408K 
 3: EX-27       Financial Data Schedule                                1      7K 


10-Q   —   Surgical Care Form 10-Q
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 1. Financial Statements
7Item 2. Management's Discussion and Analysis of Its Financial Condition and Results of Operations:
9Item 1. Legal Proceedings. - None
"Item 2. Changes in Securities. - None
"Item 3. Defaults Upon Senior Securities. - None
"Item 4. Submission of Matters to a Vote of Security Holders. - None
"Item 5. Other Information. - None
"Item 6. Exhibits and Reports on Form 8-K
10-Q1st Page of 11TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended March 31, 1995, commission file number 0-13364 -------------- ---------------- SURGICAL CARE AFFILIATES, INC. ----------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) DELAWARE ----------------------------------------------------------------------------- (State or other jurisdiction of incorporation or organization) 62-1149229 ----------------------------------------------------------------------------- (I. R. S. Employer Identification No.) Registrant's telephone number, including area code (615) 385-3541 -------------------------- 102 Woodmont Blvd, Suite 610, Nashville, TN 37205 ------------------------------------------------- Former name, former address and former fiscal year, if changed since last report. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No --- --- The condensed financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. All adjustments necessary to a fair statement of the results of this period reported have been included. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed financial statements be read in conjunction with the financial statements and the notes thereto included in the Company's latest annual report on Form 10-K. Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the period covered by this report. Common stock, par value $.25 per share, shares outstanding 38,955,085 at March 31, 1995.
10-Q2nd Page of 11TOC1stPreviousNextBottomJust 2nd
PART I -- FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS SURGICAL CARE AFFILIATES, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS [Download Table] MARCH 31, DECEMBER 31, 1995 1994 ------------ ------------- ASSETS ------ Current assets: Cash $ 39,060,301 $ 31,222,963 Marketable securities 294,639 294,639 Accounts receivable, less allowance for doubtful accounts of $4,452,372 in 1995 and $4,160,260 in 1994 31,929,368 34,801,079 Other receivables 772,224 701,965 Supplies 4,681,043 4,562,518 Prepaid expenses and other current assets 1,701,826 742,911 Deferred income taxes 9,260,259 9,260,259 ------------ ------------ Total current assets 87,699,660 81,586,334 ------------ ------------ Property & equipment, including leased properties: Land & improvements 32,244,504 31,972,686 Building 67,177,472 66,289,162 Equipment, furniture and fixtures 108,915,721 106,690,800 Construction in progress 2,188,462 1,998,495 ------------ ------------ 210,526,159 206,951,143 Less: accumulated depreciation and amortization (61,550,158) (57,969,075) ------------ ------------ Net property & equipment 148,976,001 148,982,068 Other assets: Excess of cost over fair value of net assets acquired 114,300,992 109,149,364 Other assets 592,733 625,828 ------------ ------------ $351,569,386 $340,343,594 ============ ============ The notes to consolidated financial statements are an integral part of these statements.
10-Q3rd Page of 11TOC1stPreviousNextBottomJust 3rd
SURGICAL CARE AFFILIATES, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS [Download Table] MARCH 31, DECEMBER 31, 1995 1994 ------------ ------------ LIABILITIES & SHAREHOLDERS' EQUITY ---------------------------------- Current liabilities: Accounts payable - trade $ 5,577,805 $ 5,889,642 Accrued liabilities 12,578,044 15,658,612 Accrued loss on disposal of surgery centers 1,703,208 5,629,000 Current portion of long-term obligations and notes payable 10,119,162 10,119,162 Income taxes payable 18,380,290 14,737,873 Distributable to minority interests 4,500,000 4,500,000 ------------ ------------ Total current liabilities 52,858,509 56,534,289 ------------ ------------ Long-term obligations: Notes payable & other long-term debt 47,442,913 42,269,224 Capital lease obligations - related parties 4,067,635 7,447,761 ------------ ------------ Total long-term obligations 51,510,548 49,716,985 ------------ ------------ Deferred income taxes 3,845,939 3,845,939 ------------ ------------ Minority interests 32,965,595 33,623,872 ------------ ------------ Shareholders' equity: Common stock, par value $.25, 100,000,000 shares authorized, 39,427,485 and 39,110,622 shares issued, and 38,955,085 and 38,638,222 shares outstanding in 1995 and 1994, respectively 9,856,872 9,777,656 Treasury stock at cost,472,400 shares in 1995 and 1994, respectively (6,094,078) (6,114,778) Additional paid in capital 95,996,839 91,159,880 Retained earnings 110,629,162 101,799,751 ------------ ------------ Total shareholders' equity 210,388,795 196,622,509 ------------ ------------ $351,569,386 $340,343,594 ============ ============ The notes to consolidated financial statements are an integral part of these statements.
10-Q4th Page of 11TOC1stPreviousNextBottomJust 4th
SURGICAL CARE AFFILIATES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME [Download Table] THREE MONTHS THREE MONTHS ENDED ENDED MARCH 31, MARCH 31, 1995 1994 ------------ ------------ Net revenue $65,106,351 $52,148,320 Operating costs: Costs of providing healthcare services (34,168,337) (28,142,003) Depreciation and amortization (4,338,978) (3,900,668) Provision for doubtful accounts (921,983) (980,017) ----------- ----------- Operating income 25,677,053 19,125,632 General, administrative and development expenses (1,561,131) (1,153,772) Interest and other expenses (1,162,284) (2,057,544) Interest and other income 477,582 847,909 Gain on sale of MCA stock 0 3,419,612 ----------- ----------- Income before minority interests and income taxes 23,431,220 20,181,837 Minority interests in (earnings) of partnerships (6,100,441) (4,416,546) ----------- ----------- Income before income taxes and cumulative effect of change in accounting principle 17,330,779 15,765,291 Income tax provision (6,932,312) (7,686,116) ----------- ----------- Income before cumulative effect of change in accounting principle 10,398,467 8,079,175 Cumulative effect of change in accounting principle, net of income tax benefit of $1,403,437 0 (2,105,155) ----------- ----------- Net income $10,398,467 $ 5,974,020 =========== =========== Net Income Per Common & Common Equivalent Share Before cumulative effect of change in accounting principle $ 0.27 $ 0.21 Cumulative effect of change in accounting principle 0.00 (0.05) ----------- ----------- $ 0.27 $ 0.16 =========== =========== Weighted average number of common and common equivalent shares outstanding 39,091,979 38,876,222 =========== =========== The notes to consolidated financial statements are an integral part of these statements.
10-Q5th Page of 11TOC1stPreviousNextBottomJust 5th
SURGICAL CARE AFFILIATES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS [Enlarge/Download Table] Three Months Ended ---------------------------- MARCH 31, MARCH 31, 1995 1994 ----------- ----------- Cash Flows From Operating Activities: Net Income $10,398,467 $ 5,974,020 Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: Cumulative Effect of Change in Accounting Principle 0 2,105,155 Depreciation and Amortization 4,338,978 3,900,668 Provisions for Losses on Accounts Receivable 921,983 980,017 Minority Interests in Earnings of Partnerships 6,100,441 4,416,546 Deferred Income Taxes 0 858,127 Changes in Assets and Liabilities Net of Effect of Acquisitions: Decrease in Accounts Receivable 1,949,728 1,688,367 (Increase) Decrease in Other Receivables (70,259) 3,309,552 (Increase) Decrease in Supplies (118,525) 113,936 Increase in Prepaid Expenses and Other Current Assets (958,915) (1,125,118) Decrease (Increase) in Other Assets 33,095 (464,182) Increase in Excess of Cost over Fair Value of Net Assets Acquired (1,815,995) (2,722,175) Decrease in Accounts Payable - Trade (311,837) (1,157,750) Decrease in Accrued Liabilities (3,080,568) (512,763) Decrease in Accrued Loss on Disposal of Surgery Centers (3,925,792) 0 Increase in Income Taxes Payable 3,642,417 6,777,359 ----------- ----------- Net Cash Provided by Operating Activities 17,103,218 24,141,759 ----------- ----------- Cash Flows From Investing Activities: Decrease in Temporary Investments 0 31,108 Decrease in Marketable securities 0 7,010,219 Capital Expenditures (3,575,016) (9,820,427) Acquisitions less Cash Acquired of $0 in 1995, $ 75,000 in 1994 0 (4,363,371) ----------- ----------- Net Cash Used in Investing Activities (3,575,016) (7,142,471) ----------- ----------- Cash Flows From Financing Activities: Net Borrowings Under Line-of-Credit Agreement 31,076,792 0 Payments on Long-Term Obligations (29,283,229) (9,613,361) Proceeds From Long-Term Obligations 0 1,334,290 Proceeds From Issuance of Common Stock 822,647 830,481 Dividends on Common Stock for the Treasury 20,700 0 Dividends Paid (1,569,056) (1,551,167) Distributions to Minority Interests (6,110,734) (5,131,341) Decrease in Distributable to Minority Interests 0 (261,219) (Decrease) Increase in Minority Interests (647,984) 594,720 ----------- ----------- Net Cash Used in Financing Activities (5,690,864) (13,797,597) ----------- ----------- Net Increase in Cash & Cash Equivalents 7,837,338 3,201,691 Cash & Cash Equivalents at Beginning of Period 31,222,963 23,877,186 ----------- ----------- Cash & Cash Equivalents at End of Period $39,060,301 $27,078,877 =========== =========== For purposes of the statements of cash flows, the Company considers all certificates of deposits and highly liquid marketable securities with a maturity of three months or less to be cash equivalents. Cash & Cash Equivalents at End of Period $39,060,301 $27,078,877 Temporary Investments 0 5,254,675 ----------- ----------- Cash and Temporary Investments $39,060,301 $32,333,552 =========== =========== The notes to consolidated financial statements are an integral part of these statements.
10-Q6th Page of 11TOC1stPreviousNextBottomJust 6th
SURGICAL CARE AFFILIATES, INC. NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 - BASIS OF FINANCIAL STATEMENTS The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X, "Interim Financial Statements," and do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. The financial statements have been prepared in conformity with accounting principles and practices (including consolidation practices) reflected in the Company's Annual Report on Form 10-K for the year ended December 31, 1994, and in the opinion of management, include all adjustments (consisting only of normal recurring adjustments), necessary for a fair presentation of the Company's financial position as of March 31, 1995, and results of its operations and cash flows for the three months ended March 31, 1995 and 1994. The results of operations for the three months ended March 31, 1995 are not necessarily indicative of the results that can be expected for the year ending December 31, 1995. All significant intercompany balances and transactions have been eliminated in the consolidated financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 1994. NOTE 2 - RECLASSIFICATIONS Reclassifications of certain amounts in the 1994 consolidated financial statements have been made to conform to the 1995 presentation of accounts.
10-Q7th Page of 11TOC1stPreviousNextBottomJust 7th
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF ITS FINANCIAL CONDITION AND RESULTS OF OPERATIONS: Surgical Care Affiliates, Inc. operates 63 outpatient surgery centers, nine of which were acquired or built in 1994. The Company began the quarter with 65 centers but closed two of them in the first quarter. RESULTS OF OPERATIONS - FIRST QUARTER Revenue for the first quarter increased 25% to $65.1 million. Earnings per share before cumulative effect of change in accounting principle increased 29% to $.27 compared to $.21 in 1994. The increase in revenue of 25% is due primarily to a 16% rise in same center revenue. The remaining growth in revenue came from new centers. The same center revenue increase is comprised of a 12% growth in volume and 4% increase in pricing and the intensity of surgical procedures performed. The 16% increase is the largest quarterly increase experienced in same center revenue in several years. The increase is partially the result of an increase in activity at centers joint ventured with hospitals. The case volume in the first quarter of 1994 was also reduced by bad weather. Management expects total same center revenue to increase by 6 - 10% for the remainder of 1995. The costs of providing healthcare services increased 21%. The increase is due to the addition of 5 new centers and the increase of 16% in same center revenues since the first quarter of 1994. Interest and other expenses decreased from $2.1 million in 1994 to $1.2 million in 1995. In the first quarter of 1994, the Company recorded an expense of $950,000 to relocate two surgery centers. Interest and other income decreased because the Company did not record any development fee revenue during the first quarter of 1995 that is earned when new centers are developed. General and administrative expenses increased due to an increase in corporate staffing and other activities to manage the growth in surgery centers. During the first quarter of 1994, the Company sold shares of stock in Medical Care America at a pre-tax gain of $3.4 million. All of the stock was sold in 1994. Effective January 1, 1994, the Company changed its accounting policy for deferred development and pre-opening costs. As a result of the change, the Company recorded a cumulative effect of change in accounting principle of $2.1 million for the first quarter of 1994. The Company now expenses deferred development and pre-opening costs as incurred. The change in accounting for deferred development and pre-opening costs did not have a material impact on the Company's net income for the first quarter of 1995.
10-Q8th Page of 11TOC1stPreviousNextBottomJust 8th
The Company's effective tax rate was 49% in the first quarter of 1994 compared to 40% in 1995. The decrease occurred because of a $1 million charge to provide for certain income tax contingencies in 1994. BALANCE SHEET AMOUNTS The Company's cash position increased by $8 million from year end. The increase is due to net income earned in the first quarter. The Company did not make any acquisitions in the first quarter which historically has been the largest use of cash. Accounts receivable decreased since December 31, 1994, due to seasonal fluctuations. The Company's receivables typically rise before year end due to the high volume of surgery in the fourth quarter. Excess of cost over fair value of net assets acquired (goodwill) increased due to the payment of deferred purchase price consideration incurred from past acquisitions. LIQUIDITY AND CAPITAL RESOURCES The Company expects to open four to five surgery centers in 1995 that currently are or will be under construction. The Company also expects to acquire four centers that should close before the end of the second quarter. The Company expects to pay cash to purchase these centers. Funding will be provided from operations or from draws on the Company's lines of credit. As in previous periods, the principal source of the Company's cash is generated from its operations. The Company believes that it has ready access to third party resources (primarily banks) to finance its growth to the extent that the growth requirements exceed cash generated from operations. In April 1995, the Company entered into an agreement to refinance substantially all of its short and long term debt. Under the terms of the new five year agreement, the Company will pay interest at LIBOR plus 50 basis points, compared to the old rate of LIBOR plus 130-200 basis points. The new loan is unsecured except for a negative pledge on assets and contains certain financial covenants.
10-Q9th Page of 11TOC1stPreviousNextBottomJust 9th
SURGICAL CARE AFFILIATES, INC. AND SUBSIDIARIES FOR THE THREE MONTHS ENDED MARCH 31, 1995 Part II. Other Information Item 1. Legal Proceedings. - None. Item 2. Changes in Securities. - None. Item 3. Defaults Upon Senior Securities. - None. Item 4. Submission of Matters to a Vote of Security Holders. - None Item 5. Other Information. - None. Item 6. Exhibits and Reports on Form 8-K. (A) Exhibits (1) Credit Agreement dated April 12, 1995 by and among Surgical Care Affiliates, Inc., SCA-Management Company, SCA Investment Company, the Lenders Listed therein and Third National bank in Nashville as Agent (2) Financial Data Schedule (for SEC use only) (B) Reports on Form 8-k. - None.
10-Q10th Page of 11TOC1stPreviousNextBottomJust 10th
SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SURGICAL CARE AFFILIATES, INC. ------------------------------ (Registrant) /s/ Tarpley B. Jones ------------------------------- Tarpley B. Jones Senior Vice President and Chief Financial Officer (Principal Financial and Duly Authorized Officer) On behalf of Registrant Date: May 10, 1995
10-QLast Page of 11TOC1stPreviousNextBottomJust 11th
EXHIBIT INDEX [Download Table] Number Description ------ ---------------------------------------------------------------------------- 10.1 Credit Agreement dated April 12, 1995 by and among Surgical Care Affiliates, Inc., SCA-Management Company, SCA Investment Company, the Lenders Listed therein, and Third National Bank in Nashville as Agent 27 Financial Data Schedule (For SEC use only)

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘10-Q’ Filing    Date First  Last      Other Filings
12/31/956
Filed on:5/11/95DEF 14A
5/10/9510
4/12/95911
For Period End:3/31/9519
12/31/946810-K405,  11-K
3/31/946
1/1/947
 List all Filings 
Top
Filing Submission 0000950144-95-001269   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 6:09:35.2am ET